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Abstract
miRNAs have been found to repress gene expression at posttranscriptional level in cells. Studies have shown that
expression of miRNAs is tissue-specific and developmental-stage-specific. The mechanism behind this could be explained by
miRNA pathways. In this study, totally 54 miRNAs were analysed in 7 matched human foetal and adult organs (brain, colon,
heart, kidney, liver, lung and spleen) using real-time PCR. Quantitative analysis showed that a big proportion of the 54
miRNAs have higher general expression in the organs of the foetal period than the adult period, with the exception of the
heart. The miRNA gene promoter methylation level in the adult stages was higher than in the foetal stages. Moreover, there
is a high general expression level of several miRNAs in both stages of brain, kidney, liver, lung and spleen, but not seen in
colon and heart. Our results indicate that the miRNAs may play a bigger role in the foetal stage than the adult stage of brain,
colon, kidney, liver, lung and spleen. The majority of the miRNAs analysed may play an important role in the growth and
development of brain, kidney, liver, lung and spleen. However, a minority of the miRNAs may be functional in colon and
heart.
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Introduction
The expression inhibition of genes can be generated by
endogenous microRNAs (miRNAs). The miRNAs are non-coding
RNAs that inhibit translations of target mRNAs or cleave the
target mRNAs. The primary miRNAs (pri-miRNAs) are tran-
scripts of the miRNA genes in the genome. The pri-miRNAs are
turned into approximate 70 nucleotides of hairpin structures,
called precursor miRNAs (pre-miRNAs), by Drosha, in the
nucleus. The pre-miRNAs are then transported to the cytoplasm
by Exportin-5 and are cleaved to about 22 nucleotides of mature
miRNAs by Dicer enzymes [1].
Previous studies show that miRNAs are involved in some
biological processes. Let-7 and lin-4 regulate the timing of early
andlate larval developmentaltransitioninCaenorhabditis elegans [2,3].
Some miRNAs play a role in flowering, leaf development and
embryonic patterning in plants [4–6]. Moreover, in Drosophila, miR-
14 and bantam are found to be a key regulator in cell apoptosis and
growth and fat metabolism [7,8]. It has been shown that the
miRNAs are involved in development and differentiation of human
cells [8–12]. Furthermore, miRNAs exhibit tissue-specific and
developmental-stage-specific expression [13,14]. In this study seven
organs (brain, colon, heart, kidney, liver, lung and spleen) at foetal
and adult stage were studied for miRNA expression. The 7 organs
are crucial for the human body and have multiple functions. It can
be speculated that a special group of miRNAs may be involved in
regulation of function and dysfunction, differentiation, growth and
development of these organs.
To date, a few articles have reported miRNA identification in
human foetal and adult organs [15–18]. More work is necessary to
gain an overview of expression of the miRNAs during the process
of organ growth and development. Here we chose 54 miRNAs for
quantitative analysis, of which the 31 were identified from the
foetal livers in our previous studies [17,18]. The rest were chosen
from the miRNA database. Expression of the 54 miRNAs were
tissue specific and involved in the growth and development of cells
and tumorigenesis according to the miRNA database and
literatures. We then quantified those miRNAs in the 7 matched
human foetal and adult organ tissues using real-time PCR.
Results
The miRNA expression in the 7 matched human organs
In order to understand whether the expression level of the
miRNAs differs in different stages and different organs, a
quantitative PCR was performed. The relative expression level
was calculated and compared (Fig. 1 and Table 1). A high level of
miR-1 was identified in the adult spleen, and however a moderate
level of miR-1 was seen in the foetal heart. The let-7 family (7a, 7b,
7c, 7d, 7f and 7g) showed a high level expression in the foetal brain.
The high level of miR-9 and miR-125b was also detected in the
foetal brain. In contrast, the miR-23a and miR-125a-5p exhibited
the high level in the adult brain. The miR-21 was expressed highly
in the foetal lung, spleen and kidney. A high level of miR-26a and
miR-26b was identified in the foetal lung, kidney and spleen. The
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Also the highest level of miR-125a-5p was identified in both foetal
and adult colon. The miR-451 was highly expressed in the foetal
and adult lung, foetal kidney, liver and spleen.
Comparison of the total miRNA expression in the 2
stages
The total expression level of the miRNAs at each stage was
calculated and compared (Fig. 2). The total level for 6 organs
(brain, colon, kidney, liver, lung and spleen) at the foetal stage was
significantly higher than at the adult stage (all p,0.001). No
difference was observed between the foetal and adult stages for the
heart organ (p=0.78).
Comparison of the total miRNA expression in the 7
organs
For the 7 foetal organs, the highest total miRNA expression
level was seen in brain. The moderate total expression level was
identified in the organs of kidney, liver, lung and spleen. The colon
and heart organs exhibited lower total expression level (Fig. 2). For
the 7 adult organs, higher total expression level was seen in the
brain and liver organs. The moderate total expression level was
detected in the kidney, lung and spleen organs. The colon and
heart organs also showed lower total expression level compared to
the foetal stage (Fig. 2).
Comparison of miRNA gene methylation level in the 2
stages
The gene promoter methylation of let-7a was examined in
the foetal and adult brain, heart and colon organs (Fig. 3). The
methylation level was calculated. For foetal and adult brains,
the scores were 66% and 85% respectlvely. The foetal and
adult colons exhibited 70% and 86% respectively. Also, 73% and
78% were for foetal and adult hearts respectively. In concor-
dance, the expression level for the let-7a in the foetal brain
was 144 fold that in the adult brain. For the colon organs, the
ratio between foetal and adult stages was 119, and in the hearts,
it was 20.
Figure 1. Expression profiles of 54 mature miRNAs in the 7 matched organ samples. Samples and miRNAs are displayed in rows and
columns, respectively. The relative expression values ranged from +7 log2 to 27 log2, which are exhibited with different colors. The bright red colors
represent the highest expression levels, the light green colors represent the lowest expression levels. f, foetal; a, adult.
doi:10.1371/journal.pone.0028730.g001
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Fetal Brain Fetal Colon Fetal Heart Fetal kindey Fetal Liver Fetal Lung Fetal Spleen
hsa-let-7a hsa-mir-125a-5p hsa-mir-1 hsa-mir-30d hsa-mir-122 hsa-let-7a hsa-let-7a
hsa-let-7c hsa-mir-423-5p hsa-let-7a hsa-let-7a hsa-mir-483-5p hsa-mir-21 hsa-let-7c
hsa-let-7f hsa-mir-483-5p hsa-let-7f hsa-mir-30a hsa-mir-451 hsa-let-7f hsa-mir-21
hsa-let-7b hsa-let-7b hsa-let-7c hsa-mir-125b hsa-let-7c hsa-mir-451 hsa-mir-26b
hsa-let-7d hsa-let-7d hsa-let-7d hsa-mir-26b hsa-mir-26b hsa-mir-26a hsa-mir-26a
hsa-mir-125b hsa-mir-122 hsa-let-7b hsa-mir-21 hsa-let-7a hsa-mir-26b hsa-let-7f
hsa-mir-9 hsa-mir-130a hsa-mir-26a hsa-mir-26a hsa-mir-26a hsa-let-7c hsa-let-7b
hsa-mir-26a hsa-mir-23a hsa-mir-26b hsa-let-7f hsa-let-7f hsa-let-7d hsa-let-7d
hsa-let-7g hsa-let-7c hsa-mir-21 hsa-let-7c hsa-let-7d hsa-let-7b hsa-mir-451
hsa-mir-125a-5p hsa-mir-92b hsa-mir-23a hsa-mir-125a-5p hsa-mir-23a hsa-mir-16 hsa-mir-16
Adult Brain Adult Colon Adult Heart Adult Kidney Adult Liver Adult Lung Adult Spleen
hsa-mir-125a-5p hsa-mir-125a-5p hsa-mir-423-5p hsa-mir-125b hsa-mir-122 hsa-mir-451 hsa-let-7c
hsa-mir-23a hsa-mir-211 hsa-mir-483-5p hsa-mir-31 hsa-mir-92b hsa-mir-92b hsa-mir-1
hsa-mir-125b hsa-mir-423-5p hsa-mir-19b hsa-mir-122 hsa-let-7b hsa-let-7c hsa-mir-125a-5p
hsa-mir-423-5p hsa-mir-92b hsa-mir-92b hsa-let-7b hsa-let-7c hsa-let-7a hsa-let-7a
hsa-mir-139-5p hsa-mir-212 hsa-let-7b hsa-mir-150 hsa-let-7a hsa-let-7b hsa-mir-192
hsa-mir-483-5p hsa-mir-183 hsa-mir-23a hsa-mir-211 hsa-mir-21 hsa-mir-26b hsa-mir-204
hsa-mir-92b hsa-mir-483-5p hsa-mir-183 hsa-mir-103 hsa-mir-495 hsa-mir-26a hsa-mir-21
hsa-let-7b hsa-mir-125b hsa-mir-122 hsa-let-7c hsa-mir-26b hsa-mir-21 hsa-let-7d
hsa-mir-196a hsa-mir-196a hsa-mir-211 hsa-mir-30d hsa-mir-30d hsa-mir-16 hsa-let-7f
hsa-mir-183 hsa-mir-139-5p hsa-mir-192 hsa-let-7a hsa-mir-139-5p hsa-let-7f hsa-mir-139-5p
doi:10.1371/journal.pone.0028730.t001
Figure 2. Comparison of the total expression levels of all 54 miRNAs in the seven matched organ tissues (addition of the relative
expression level for each miRNA). The levels at the foetal stage are significantly higher than at the adult stages except the heart organs.
doi:10.1371/journal.pone.0028730.g002
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Gene expression exhibits tissue and developmental-stage
specificity. The mechanism behind this could be that epigenetic
events, including methylation modification and miRNAs actions,
regulate transcription and translation of genes at certain tissues
and developmental stages. In this study we analysed expression
level of 54 miRNAs in 7 matched human organ tissues. These
tissues were from 2 different stages of development: one was 30
weeks of foetal stage and another was 18 years of adult stage.
In general the total expression level of the 54 miRNAs was
higher at the foetal stage than at the adult stage, except for the
heart (Fig. 2). This is in line with our previous findings in the liver
[18]. It indicates that the target gene functions are repressed at the
foetal stage. At this stage, the embryo cells are in the process of
differentiation. It is conceivable that the highly expressed miRNAs
could be involved in embryo differentiation. The mechanism
behind this difference in expression of miRNA between the foetal
and adult stage is unknown, but one explanation could be higher
gene methylation status in the adult [19]. We analysed and
compared the gene promoter methylation level of let-7a, and
found that the methylation level in the adult stages was higher than
in the foetal stages (Fig. 3). In addition to transcriptional control
and other mechanism of gene regulation, it can be inferred that at
the foetal stage the inhibition of gene functions are mainly induced
by the miRNAs, while in adults gene methylation plays a bigger
role. No difference was seen for the total expression level between
the foetal and adult stage of heart, and hearts at both stage showed
very low level of miRNA expression compared to other organs
(Fig. 2). This suggests that few miRNAs are implicated in the
growth and development of the foetal heart at the stage of 30
weeks. It has been demonstrated that human cardiac development
spans 6 weeks to 9 weeks of the foetal stage [20]. Thus, at the stage
of 30 weeks, a low level of the general miRNA expression was
seen, probably owing to the completed cardiac development.
Surprisingly, the total expression level in the foetal brain was much
higher than in the other foetal organs (Fig. 2), suggesting that those
miRNAs play a big role in the growth and development of the
foetal brain.
The miRNAs whose expression level ranks top 10 in each organ
were analysed (Table 1). Involvement of different miRNAs can be
seen in the foetal and adult organs. It indicates that different
miRNAs play a role in the foetal and adult organs respectively.
However, some miRNAs were involved in both foetal and adult
stages, suggesting that they are conservative during the cell growth
and development. For the brain, the let-7 family seems to play
a bigger role at the foetal stage, however the miR-125a-5p and
miR-23a do at the adult stage. In the foetal heart, miR-1 showed a
highest level, however, the highest level is for miR-423-5p in the
adult heart. The miR-30d and miR-125b display the highest level
at the foetal and adult stages of kidneys, respectively. In contrast,
the miR-122 was expressed highly in both foetal and adult liver.
Also, the miR-451 displayed high expression level in both foetal
and adult lungs.
Interestingly, the let-7 family was identified at a moderate to
high level in the all foetal organs (Fig. 1 and Table 1). Members of
the let-7 family can act as tumour suppressors and play a critical
role in cell-cycle control with respect to differentiation and
tumourigenesis [21]. The moderate to high expression of the let-7
family detected in the foetal organs suggests a certain level of
negative regulation of cell growth. It has been reported that miR-
125a-5p inhibits the proliferation of human gastric cancer cells in
combination with trastuzumab [22]. The miR-23a promotes the
growth of gastric adenocarcinoma cells [23]. Thus both miR-
125a-5p and miR-23a can regulate cell growth.
The relatively high expression of miR-1 and mir-423-5p that we
detected in foetal and adult hearth, respectively, is of interest. A
previous study shows that miR-1 regulates differentiation and
proliferation in human-derived cardiomyocyte progenitor cells
[24]. Also, it seems that the miR-423-5p can act as a circulating
biomarker for heart failure [25]. Hence both miR-1 and miR-423-
5p are linked to establishment of structure and function of heart.
The miR-30d was found to promote tumor invasion and
metastasis in hepatocellular carcinoma [26]. In contrast, the miR-
125b functions as a tumor suppressor in invasive breast cancer
[27]. Therefore both miRNAs are involved in the tumour
invasiveness. The liver-specific miR-122 displayed moderate to
high expression levels in the foetal and adult brain, foetal colon,
adult kidney, and foetal and adult liver (Fig. 1). The target genes of
miR-122 include PINX1_HUMAN. This gene may inhibit cell
proliferation and act as a tumour suppressor. It has been suggested
that inhibition of this gene may promote cell growth [28]. Studies
uncovered that the miR-451 functions as a tumor suppressor in
human non-small cell lung cancer and glioma cells [29,30]. The
high level of miR-451 detected in the foetal and adult lung, foetal
kidney, liver and spleen, indicates that miR-451 plays a role as a
negative regulator in the growth and development of those organs.
In conclusion the expression pattern of the analysed miRNAs is
both organ and stage specific. The majority of the 54 miRNAs
may play a bigger role in the foetal stage than the adult stage of
brain, colon, kidney, liver, lung and spleen. These miRNAs may
be involved in the growth and development of brain, kidney, liver,
lung and spleen. However, a minority of them may regulate their
target genes in colon and heart.
Figure 3. Promoter methylation assessment of let-7a gene by COBRA with BstUI. The foetal and adult brains, hearts and colons were
analysed. Symbol ‘‘+’’ means that PCR products (723 bp) were digested with BstUI, and ‘‘2’’ means digestion without BstUI.
doi:10.1371/journal.pone.0028730.g003
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Ethics Statement
This research has been approved by the review board of
Huazhong University of Science and Technology. We obtained
tissue samples with written informed consent from the participants
involved in the study. The ethics committee of Huazhong
University of Science and Technology specifically approved the
procedures.
Samples
The 7 foetal organ tissues were obtained from a female foetus of
30 weeks, delivered due to an adenoma in the right lung, in Tongji
hospital, Wuhan, Hubei, China. The fetus died shortly after it was
delivered. The lung tissue obtained was from the left normal lung.
The mother of the foetus was a healthy individual. The 7 adult
organ tissues were obtained from a female aged 18 years, who had
died due to severe injury, at the Department of Forensic Science,
Tongji Medical College, Huazhong University of Science and
Technology.
Isolation of small RNA
Small RNAs (#200 nt) were isolated from the matched 7 organ
tissues using a mirVana
TM miRNA isolation kit (Ambion, Austin,
TX) following the manufacturer’s instructions. About fifty
milligrams of tissue were used and the small RNA was eluted in
100 ml RNAse-free water. The RNA concentration was tested by
UV absorbance at 260 nm.
Establishment of cDNA library
The small RNAs were polyadenylated at 37uC for 30 min in
50 ml reaction volume using ,1 mg RNA and 5 U poly(A)
polymerase (New England Biolabs). Then the poly(A)-tailed small
RNA was purified through phenol/chloroform extraction and
ethanol precipitation. Reverse transcription was conducted using
the entire poly(A)-tailed RNA and 1 mg RT primer (59-CGC TAC
GTA ACG GCA TGA CAG TG(T)24-39) with 200 U of
SuperScript III reverse transcriptase (Invitrogen) according to
the manufacturer’s instructions.
miRNA quantitative analysis using real-time PCR
Real-time PCR was carried out in a Stratagene MX-4000
system with the miRNA-specific forward primers (Table S1) and
reverse primer (59-CGC TAC GTA ACG GCA TGA CAG TG-
39) , and TransStart SYBR green qPCR supermix (TransGen,
Biotech) following the manufacturer’s instructions. The 20 ml
reactions including 0.5 ml of RT products, 16TransStart SYBR
green qPCR supermix and 0.5 mM forward and reverse primers
were incubated at 95uC for 5 min, followed by 40 cycles of 95uC
for 10 sec, 55uC for 15 sec and 72uC for 20 sec. Melting curves for
each PCR were carefully monitored to avoid non-specific
amplification. The U6 small nuclear RNA was used as internal
control. Each miRNA was analysed in duplicate. The relative level
(RL) of each miRNA expression was calculated with 2
2DCt
method, and the data were presented as log2 of RL of target
miRNAs. Results were visualised with GENESIS (Alexander
Sturn, Institute for Genomics and Bioinformatics, Graz University
of Technology).
DNA isolation and miRNA gene methylation assessment
For the foetal and adult brain, heart and colon tissues, DNA was
extracted using DNA isolation kit (Sangon, Shanghai, China). The
extracted DNA was converted using EZ DNA Methylation Kit
(Zymo Research Corporation, Orange, CA, USA). The promoter
methylation of the let-7a gene was assessed using combined
bisulfite restriction analysis (COBRA) with BstUI [31]. The
intensity of the bands detected by COBRA was examined by
using QUANTITY ONE 4.62 (Bio-Rad). The methylation level
was determined by calculating the intensity percentages of the 4
smaller digestion bands (Fig. 3).
Statistical analysis of miRNA expression
A two-tailed t-test was used to assess the miRNA expression
level difference at the two stages.
Supporting Information
Table S1 Fifty-four miRNAs specific primers for real-
time PCR.
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